• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
APX
Click for more information
6.15% 69.0¢

APPEN LIMITED - Corporate Spotlight

Market Cap $152.9M  ! watchlist Created with Sketch. Add to my watchlist
Technology Information Technology Services

Appen Limited (Appen) is an Australia-based company. The Company is engaged in providing... Appen Limited (Appen) is an Australia-based company. The Company is engaged in providing data services for deep learning and generative artificial intelligence (AI) systems. The Company operates through two segments: Global Services and New Markets. The Global Services represent the services that the Company provides to its five United States technology customers (Global customers) using the customer's data annotation platforms and tools. New Markets comprise Appen's data annotation platform and tools (Global Product), and the enterprise, government, and China business units. New Markets also include Quadrant geolocation and Point-of-Interest (POI) data capabilities. Its Annotation Platform is the platform that both customers and internal teams used to design, run and manage data annotation tasks. The Company serves various industries, including technology, automotive, financial services, healthcare, retail, and government agencies.More

No Corporate Spotlight currently available.

(20min delay)
Last
69.0¢ 		Change
0.040(6.15%) 		Mkt cap ! $152.9M
Open High Low Value Volume
66.0¢ 69.5¢ 65.0¢ $2.746M 4.060M

Buyers (Bids)

No. Vol. Price($)
1 36501 69.0¢
 

Sellers (Offers)

Price($) Vol. No.
69.5¢ 236480 8
View Market Depth
Last trade - 16.10pm 23/04/2024 (20 minute delay) ?
Last
68.5¢ 		  Change
0.040 ( 6.88 %)
Open High Low Volume
67.0¢ 69.5¢ 65.0¢ 973427
Last updated 15.59pm 23/04/2024 ?
APX (ASX) Chart

Top Stories

Regal copper grades at Gascoyne play see shares jump 33% for Augustus

Augustus Minerals is reporting high grade copper rock chip results at Ti-Tree in WA based on recent fieldwork.
PharmAust CEO's sayanora triggers stock plunge Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Are there gains to be made with the grocery giants? There is a growing storm of controversy around Coles (ASX:COL) and Woolworths (ASX:WOW) as they face intense scrutiny over price hikes and supplier pressures in a Senate inquiry. This raises an interesting question as to whether investors should cut ties with these corporate giants or wheth...
AML3D secures Australian defence government contract AML3D signed a contract with the Australian Government Defence Science and Technology Group (DSTG) to supply components for marine defence
Tamboran steps on the gas to supply the Top End Tamboran Resources has taken a significant step towards commercialising the gas resources of the Betaloo Sub Basin by signing a gas supply agreement with the Northern Territory Government.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.